Coya Therapeutics Inc. (NASDAQ: COYA)
$5.4250
+0.1150 ( +2.17% ) 10.5K
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Market Data
Open
$5.4250
Previous close
$5.3100
Volume
10.5K
Market cap
$90.64M
Day range
$5.3250 - $5.4800
52 week range
$4.7500 - $10.6899
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Feb 02, 2024 |
| 8-k | 8K-related | 12 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 04, 2024 |
| 3 | Insider transactions | 2 | Dec 29, 2023 |
| 8-k | 8K-related | 13 | Dec 20, 2023 |